New device aims to stop internal bleeding safely

NCT ID NCT07199348

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a new medical device called EmboBio to stop bleeding in the abdomen or pelvic area. The device is injected into an artery to block blood flow and control bleeding. The study will include 45 adults in France and will check if the device is safe and works well over about 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINO-PELVIC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hegp-Aphp

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.